2020-08354. Importer of Controlled Substances Application: Sigma Aldrich Co., LLC  

  • Start Preamble

    ACTION:

    Notice of application.

    DATES:

    Registered bulk manufacturer of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before May 21, 2020. Such persons may also file a written request for a hearing on the application on or before May 21, 2020.

    ADDRESSES:

    Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.

    End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In accordance with 21 CFR 1301.34(a), this is notice that on January 27, 2020, Sigma Aldrich Co., LLC, 3500 DeKalb Street, Saint Louis, Missouri 63118 applied to be registered as an importer of the following basic class(es) of controlled substances:

    Controlled substanceDrug codeSchedule
    Cathinone1235I
    Methcathinone1237I
    Mephedrone (4-Methyl-N-methylcathinone)1248I
    Gamma Hydroxybutyric Acid2010I
    Tetrahydrocannabinols7370I
    4-Bromo-2,5-dimethoxyamphetamine7391I
    4-Bromo-2,5-dimethoxyphenethylamine7392I
    2,5-Dimethoxyamphetamine7396I
    3,4-Methylenedioxyamphetamine7400I
    3,4-Methylenedioxy-N-ethylamphetamine7404I
    3,4-Methylenedioxymethamphetamine7405I
    4-Methoxyamphetamine7411I
    Dimethyltryptamine7435I
    N-Benzylpiperazine7493I
    Heroin9200I
    Normorphine9313I
    Amobarbital2125II
    Secobarbital2315II
    Nabilone7379II
    Phencyclidine7471II
    Ecgonine9180II
    Ethylmorphine9190II
    Start Printed Page 22179
    Levorphanol9220II
    Meperidine9230II
    Thebaine9333II
    Opium, powdered9639II
    Levo-alphacetylmethadol9648II

    The company plans to import the listed controlled substances for sale to research facilities for drug testing and analysis. In reference to drug code 7370 (Tetrahydrocannabinols) the company plans to import synthetic tetrahydrocannabinols. No other activities for these drug codes are authorized for this registration.

    Start Signature

    William T. McDermott,

    Assistant Administrator.

    End Signature End Supplemental Information

    [FR Doc. 2020-08354 Filed 4-20-20; 8:45 am]

    BILLING CODE 4410-09-P

Document Information

Published:
04/21/2020
Department:
Drug Enforcement Administration
Entry Type:
Notice
Action:
Notice of application.
Document Number:
2020-08354
Dates:
Registered bulk manufacturer of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before May 21, 2020. Such persons may also file a written request for a hearing on the application on or before May 21, 2020.
Pages:
22178-22179 (2 pages)
Docket Numbers:
Docket No. DEA-606
PDF File:
2020-08354.pdf